Now loading...
HDFC Securities suggests adding Alkem Laboratories shares, targeting Rs 5,700. Alkem, a large pharmaceutical company, reported its financials. Total income for the quarter was Rs 3467.27 crore. Net profit after tax stood at Rs 640.79 crore. Sales growth is expected to be moderate. Promoter holding is 55.66 percent, while FIIs hold 10.14 percent.
Now loading...